Glia: An emerging target for neurological disease therapy

Stem Cell Research and Therapy

Volumn 3, Issue 5, 2012, Pages

  Almad, Akshata A ^a   Maragakis, Nicholas J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; COPPER ZINC SUPEROXIDE DISMUTASE; NERVE GROWTH FACTOR;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ASTROCYTE; CELL DIFFERENTIATION; CELL FATE; CELL FUNCTION; CELL MIGRATION; CELL SURVIVAL; CELLULAR SECRETION; EMBRYONIC STEM CELL; GLIA; HOMOZYGOSITY; HUMAN; INTERNALIZATION; LEUKODYSTROPHY; MULTIPLE SCLEROSIS; NERVE GLIAL ANTIGEN 2 CELL; NEUROLOGIC DISEASE; OLIGODENDROGLIA; PARKINSON DISEASE; PATHOGENESIS; PELIZAUES MERZBACHER DISEASE; PLURIPOTENT STEM CELL; PRACTICE GUIDELINE; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW; RISK FACTOR; SAFETY; SPINAL CORD INJURY; STEM CELL TRANSPLANTATION; NERVOUS SYSTEM DISEASES; PATHOLOGY; PHYSIOLOGY; PROCEDURES;

CELL DIFFERENTIATION; HUMANS; NERVOUS SYSTEM DISEASES; NEUROGLIA; STEM CELL TRANSPLANTATION;

EID: 84867032837     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt128     Document Type: Review

References (71)

1. Verkhratsky AN, Butt A, Glial Neurobiology: A Textbook Chichester, UK: John Wiley & Sons 2007 xiv
2. Astrocyte dysfunction in neurological disorders: a molecular perspective. Seifert G, Schilling K, Steinhauser C, Nat Rev Neurosci 2006 7 194 206 10.1038/nrn1870 16495941
3. An inwardly rectifying K(+) channel, Kir4.1, expressed in astrocytes surrounds synapses and blood vessels in brain. Higashi K, Fujita A, Inanobe A, Tanemoto M, Doi K, Kubo T, Kurachi Y, Am J Physiol Cell Physiol 2001 281 922 C931 11502569
4. Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. Nielsen S, Nagelhus EA, Amiry-Moghaddam M, Bourque C, Agre P, Ottersen OP, J Neurosci 1997 17 171 180 8987746
5. The human blood-brain barrier glucose transporter (GLUT1) is a glucose transporter of gray matter astrocytes. Morgello S, Uson RR, Schwartz EJ, Haber RS, Glia 1995 14 43 54 10.1002/glia.440140107 7615345
6. Localization of neuronal and glial glutamate transporters. Rothstein JD, Martin L, Levey AI, Dykes-Hoberg M, Jin L, Wu D, Nash N, Kuncl RW, Neuron 1994 13 713 725 10.1016/0896-6273(94)90038-8 7917301
7. Glial cells in (patho)physiology. Parpura V, Heneka MT, Montana V, Oliet SH, Schousboe A, Haydon PG, Stout RF Jr, Spray DC, Reichenbach A, Pannicke T, Pekny M, Pekna M, Zorec R, Verkhratsky A, J Neurochem 2012 121 4 27 10.1111/j.1471-4159.2012.07664.x 22251135
8. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Baumann N, Pham-Dinh D, Physiol Rev 2001 81 871 927 11274346
9. Myelination and the trophic support of long axons. Nave KA, Nat Rev Neurosci 2010 11 275 283 10.1038/nrn2797 20216548
10. + CNS glial progenitors remain committed to the oligodendrocyte lineage in postnatal life and following neurodegeneration. Kang SH, Fukaya M, Yang JK, Rothstein JD, Bergles DE, Neuron 2010 68 668 681 10.1016/j.neuron.2010.09.009 21092857
11. PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice. Rivers LE, Young KM, Rizzi M, Jamen F, Psachoulia K, Wade A, Kessaris N, Richardson WD, Nat Neurosci 2008 11 1392 1401 10.1038/nn.2220 18849983
12. NG2 cells generate both oligodendrocytes and gray matter astrocytes. Zhu X, Bergles DE, Nishiyama A, Development 2008 135 145 157 18045844
13. Polydendrocytes: NG2 cells with many roles in development and repair of the CNS. Nishiyama A, Neuroscientist 2007 13 62 76 10.1177/1073858406295586 17229976
14. Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. Horner PJ, Power AE, Kempermann G, Kuhn HG, Palmer TD, Winkler J, Thal LJ, Gage FH, J Neurosci 2000 20 2218 2228 10704497
15. Proliferation of NG2-positive cells and altered oligodendrocyte numbers in the contused rat spinal cord. McTigue DM, Wei P, Stokes BT, J Neurosci 2001 21 3392 3400 11331369
16. NG2-positive cells in the mouse white and grey matter display distinct physiological properties. Chittajallu R, Aguirre A, Gallo V, J Physiol 2004 561 109 122 10.1113/jphysiol.2004.074252 15358811
17. Spiking and nonspiking classes of oligodendrocyte precursor glia in CNS white matter. Karadottir R, Hamilton NB, Bakiri Y, Attwell D, Nat Neurosci 2008 11 450 456 10.1038/nn2060 18311136
18. The mystery and magic of glia: a perspective on their roles in health and disease. Barres BA, Neuron 2008 60 430 440 10.1016/j.neuron.2008.10.013 18995817
19. Central remyelination restores secure conduction. Smith EJ, Blakemore WF, McDonald WI, Nature 1979 280 395 396 10.1038/280395a0 460414
20. Safety Study of GRNOPC1 in Spinal Cord Injury. http://clinicaltrials.gov/ show/NCT01217008
21. Transplantation of specific human astrocytes promotes functional recovery after spinal cord injury. Davies SJ, Shih CH, Noble M, Mayer-Proschel M, Davies JE, Proschel C, PLoS One 2011 6 17328 10.1371/journal.pone.0017328 21407803
22. Stem cell-based strategies for treating pediatric disorders of myelin. Goldman SA, Schanz S, Windrem MS, Hum Mol Genet 2008 17 76 R83 10.1093/hmg/ddn052 18632701
23. X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Saugier-Veber P, Munnich A, Bonneau D, Rozet JM, Le Merrer M, Gil R, Boespfl ug-Tanguy O, Nat Genet 1994 6 257 262 10.1038/ng0394-257 8012387
24. Transplantation of oligodendrocyte progenitor cells in animal models of leukodystrophies. Kondo Y, Duncan ID, Methods Mol Biol 2009 549 175 185 10.1007/978-1-60327-931-4-12 19378203
25. Shiverer: an autosomal recessive mutant mouse with myelin deficiency. Chernoff GF, J Hered 1981 72 128 6168677
26. 'Global' cell replacement is feasible via neural stem cell transplantation: evidence from the dysmyelinated shiverer mouse brain. Yandava BD, Billinghurst LL, Snyder EY, Proc Natl Acad Sci USA 1999 96 7029 7034 10.1073/pnas.96.12.7029 10359833
27. Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Windrem MS, Nunes MC, Rashbaum WK, Schwartz TH, Goodman RA, McKhann G, Roy NS, Goldman SA, Nat Med 2004 10 93 97 10.1038/nm974 14702638
28. Safety Study of Human CNS Stem Cells Transplantation in Patients with Pelizaeus-Merzbacher Disease. http://clinicaltrials.gov/show/NCT01005004
29. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Brenner M, Johnson AB, Boespflug-Tanguy O, Rodriguez D, Goldman JE, Messing A, Nat Genet 2001 27 117 120 10.1038/83679 11138011
30. Stem cells in genetic myelin disorders. Kemp K, Mallam E, Scolding N, Wilkins A, Regen Med 2010 5 425 439 10.2217/rme.10.10 20455653
31. Why does remyelination fail in multiple sclerosis? Franklin RJ, Nat Rev Neurosci 2002 3 705 714 10.1038/nrn917 12209119
32. Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. Johns TG, Kerlero de Rosbo N, Menon KK, Abo S, Gonzales MF, Bernard CC, J Immunol 1995 154 5536 5541 7537310
33. Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression. Kotter MR, Zhao C, van Rooijen N, Franklin RJ, Neurobiol Dis 2005 18 166 175 10.1016/j.nbd.2004.09.019 15649707
34. Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency. Shen S, Sandoval J, Swiss VA, Li J, Dupree J, Franklin RJ, Casaccia-Bonnefil P, Nat Neurosci 2008 11 1024 1034 10.1038/nn.2172 19160500
35. Oligodendrocyte origins. Miller RH, Trends Neurosci 1996 19 92 96 10.1016/S0166-2236(96)80036-1 9054062
36. Human neural stem cells ameliorate autoimmune encephalomyelitis in non-human primates. Pluchino S, Gritti A, Blezer E, Amadio S, Brambilla E, Borsellino G, Cossetti C, Del Carro U, Comi G, 't Hart B, Vescovi A, Martino G, Ann Neurol 2009 66 343 354 19798728
37. New prospects for human stem-cell therapy in the nervous system. Svendsen CN, Smith AG, Trends Neurosci 1999 22 357 364 10.1016/S0166-2236(99)01428-9 10407421
38. Isolation and preliminary characterization of Alzheimer plaques from pre-senile and senile dementia. Austin J, Trueb L, Hutchison J, Rinehart R, Miles B, J Neuropathol Exp Neurol 1971 30 146 5100705
39. Astrocytes accumulate A beta 42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains. Nagele RG, D'Andrea MR, Lee H, Venkataraman V, Wang HY, Brain Res 2003 971 197 209 10.1016/S0006-8993(03)02361-8 12706236
40. Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Koistinaho M, Lin S, Wu X, Esterman M, Koger D, Hanson J, Higgs R, Liu F, Malkani S, Bales KR, Paul SM, Nat Med 2004 10 719 726 10.1038/nm1058 15195085
41. Inhibition of endotoxin-induced nitric oxide synthase production in microglial cells by the presence of astroglial cells: a role for transforming growth factor beta. Vincent VA, Tilders FJ, Van Dam AM, Glia 1997 19 190 198 10.1002/(SICI)1098-1136(199703)19:3<190::AID-GLIA2>3.0.CO;2-3 9063726
42. A central role for astrocytes in the inflammatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced. Johnstone M, Gearing AJ, Miller KM, J Neuroimmunol 1999 93 182 193 10.1016/S0165-5728(98)00226-4 10378882
43. Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer's disease. Tian G, Kong Q, Lai L, Ray-Chaudhury A, Lin CL, J Neurochem 2010 113 978 989 10.1111/j.1471-4159.2010.06661.x 20193040
44. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease. Pihlaja R, Koistinaho J, Malm T, Sikkila H, Vainio S, Koistinaho M, Glia 2008 56 154 163 10.1002/glia.20599 18004725
45. Multiple cellular and molecular mechanisms are involved in human A clearance by transplanted adult astrocytes. Pihlaja R, Koistinaho J, Kauppinen R, Sandholm J, Tanila H, Koistinaho M, Glia 2011 59 1643 1657 10.1002/glia.21212 21826742
46. Early oligodendrocyte/myelin pathology in Alzheimer's disease mice constitutes a novel therapeutic target. Desai MK, Mastrangelo MA, Ryan DA, Sudol KL, Narrow WC, Bowers WJ, Am J Pathol 2010 177 1422 1435 10.2353/ajpath.2010. 100087 20696774
47. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH, Takahashi R, Misawa H, Cleveland DW, Nat Neurosci 2008 11 251 253 10.1038/nn2047 18246065
48. Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice. Wang L, Gutmann DH, Roos RP, Hum Mol Genet 2011 20 286 293 10.1093/hmg/ddq463 20962037
49. Astrocytes carrying the superoxide dismutase 1 (SOD1G93A) mutation induce wild-type motor neuron degeneration in vivo. Papadeas ST, Kraig SE, O'Banion C, Lepore AC, Maragakis NJ, Proc Natl Acad Sci USA 2011 108 17803 17808 10.1073/pnas.1103141108 21969586
50. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Haidet-Phillips AM, Hester ME, Miranda CJ, Meyer K, Braun L, Frakes A, Song S, Likhite S, Murtha MJ, Foust KD, Rao M, Eagle A, Kammesheidt A, Christensen A, Mendell JR, Burghes AH, Kaspar BK, Nat Biotechnol 2011 29 824 828 10.1038/nbt.1957 21832997
51. Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Lepore AC, Rauck B, Dejea C, Pardo AC, Rao MS, Rothstein JD, Maragakis NJ, Nat Neurosci 2008 11 1294 1301 10.1038/nn.2210 18931666
52. Human glial-restricted progenitor transplantation into cervical spinal cord of the SOD1 mouse model of ALS. Lepore AC, O'Donnell J, Kim AS, Williams T, Tuteja A, Rao MS, Kelley LL, Campanelli JT, Maragakis NJ, PLoS One 2011 6 25968 10.1371/journal.pone.0025968 21998733
53. Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis. http://clinicaltrials.gov/show/ NCT01348451
54. Glia: initiators and progressors of pathology in Parkinson's disease. Halliday GM, Stevens CH, Mov Disord 2011 26 6 17 10.1002/mds.23455 21322014
55. NACP/-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains. Wakabayashi K, Hayashi S, Yoshimoto M, Kudo H, Takahashi H, Acta Neuropathol 2000 99 14 20 10.1007/PL00007400 10651022
56. Astrocytic expression of Parkinson's disease-related A53T -synuclein causes neurodegeneration in mice. Gu XL, Long CX, Sun L, Xie C, Lin X, Cai H, Mol Brain 2010 3 12 10.1186/1756-6606-3-12 20409326
57. Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: critical role for the astrocyte. Chen PC, Vargas MR, Pani AK, Smeyne RJ, Johnson DA, Kan YW, Johnson JA, Proc Natl Acad Sci USA 2009 106 2933 2938 10.1073/pnas.0813361106 19196989
58. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F, Science 1993 260 1130 1132 10.1126/science.8493557 8493557
59. The physiological and pharmacological role of basic fibroblast growth factor in the dopaminergic nigrostriatal system. Grothe C, Timmer M, Brain Res Rev 2007 54 80 91 10.1016/j.brainresrev.2006.12.001 17229467
60. Long-term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson's disease. Svendsen CN, Caldwell MA, Shen J, ter Borg MG, Rosser AE, Tyers P, Karmiol S, Dunnett SB, Exp Neurol 1997 148 135 146 10.1006/exnr.1997.6634 9398456
61. Induction of adult human bone marrow mesenchymal stromal cells into functional astrocyte-like cells: potential for restorative treatment in Parkinson's disease. Bahat-Stroomza M, Barhum Y, Levy YS, Karpov O, Bulvik S, Melamed E, Offen D, J Mol Neurosci 2009 39 199 210 10.1007/s12031-008-9166-3 19127447
62. Damage to oligodendrocytes in the striatum after MPTP neurotoxicity in mice. Takagi S, Hayakawa N, Kimoto H, Kato H, Araki T, J Neural Transm 2007 114 1553 1557 10.1007/s00702-007-0790-9 17676428
63. Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors. Ubhi K, Rockenstein E, Mante M, Inglis C, Adame A, Patrick C, Whitney K, Masliah E, J Neurosci 2010 30 6236 6246 10.1523/JNEUROSCI.0567-10.2010 20445049
64. Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Windrem MS, Nunes MC, Rashbaum WK, Schwartz TH, Goodman RA, McKhann G, Roy NS, Goldman SA, Nat Med 2004 10 93 97 10.1038/nm974 14702638
65. Migration, fate and in vivo imaging of adult stem cells in the CNS. Sykova E, Jendelova P, Cell Death Differ 2007 14 1336 1342 10.1038/sj.cdd. 4402140 17396130
66. MR-based imaging of neural stem cells. Politi LS, Neuroradiology 2007 49 523 534 10.1007/s00234-007-0219-z 17345076
67. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW, Nat Med 2008 14 504 506 10.1038/nm1747 18391962
68. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Takahashi K, Yamanaka S, Cell 2006 126 663 676 10.1016/j.cell.2006.07.024 16904174
69. Induced pluripotent stem cell lines derived from human somatic cells. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA, Science 2007 318 1917 1920 10.1126/science.1151526 18029452
70. Survival of human induced pluripotent stem cell-derived midbrain dopaminergic neurons in the brain of a primate model of parkinson's disease. Kikuchi T, Morizane A, Doi D, Onoe H, Hayashi T, Kawasaki T, Saiki H, Miyamoto S, Takahashi J, J Parkinsons Dis 2011 1 395 412 23004586
71. Specification of transplantable astroglial subtypes from human pluripotent stem cells. Krencik R, Weick JP, Liu Y, Zhang ZJ, Zhang SC, Nat Biotechnol 2011 29 528 534 10.1038/nbt.1877 21602806